CYB5R1
NADH-cytochrome b5 reductase 1
Also known as: humb5R2, NB5R1_HUMAN, NQO3A2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHQ9
- Gene
- CYB5R1
- Ensembl
- ENSG00000159348
- Chromosome
- 1
- Canonical length
- 305 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
OverviewNCBI Gene
Predicted to enable FAD binding activity. Predicted to be involved in bicarbonate transport. Located in cytosol and mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
305 residues, UniProt reviewed canonical sequence.
>Q9UHQ9|CYB5R1
1 MGIQTSPVLL ASLGVGLVTL LGLAVGSYLV RRSRRPQVTL LDPNEKYLLR LLDKTTVSHN
61 TKRFRFALPT AHHTLGLPVG KHIYLSTRID GSLVIRPYTP VTSDEDQGYV DLVIKVYLKG
121 VHPKFPEGGK MSQYLDSLKV GDVVEFRGPS GLLTYTGKGH FNIQPNKKSP PEPRVAKKLG
181 MIAGGTGITP MLQLIRAILK VPEDPTQCFL LFANQTEKDI ILREDLEELQ ARYPNRFKLW
241 FTLDHPPKDW AYSKGFVTAD MIREHLPAPG DDVLVLLCGP PPMVQLACHP NLDKLGYSQK
301 MRFTYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYB5R1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 592 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 592 nTPM
- tongue: 288 nTPM
- heart muscle: 149 nTPM
- epididymis: 124 nTPM
- choroid plexus: 124 nTPM
- skin: 119 nTPM
Single-cell type
- syncytiotrophoblasts: 389 nCPM
- migrating cytotrophoblasts: 348 nCPM
- platelets: 305 nCPM
- extravillous trophoblasts: 269 nCPM
- parietal cells: 249 nCPM
- myonuclei: 194 nCPM
Immune cell
- classical monocyte: 57 nTPM
- total PBMC: 53 nTPM
- eosinophil: 47 nTPM
- neutrophil: 46 nTPM
- intermediate monocyte: 43 nTPM
- naive CD4 T-cell: 42 nTPM
Brain region
- choroid plexus: 68 nTPM
- pons: 65 nTPM
- midbrain: 52 nTPM
- hypothalamus: 48 nTPM
- medulla oblongata: 43 nTPM
- white matter: 39 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cytochrome-b5 reductase activity, acting on NAD(P)H
- cytochrome-b5 reductase activity, acting on NADH
- FAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Oxidoreductase FAD/NAD(P)-binding
- Flavoprotein pyridine nucleotide cytochrome reductase
- NADH:cytochrome b5 reductase-like
- Flavoprotein pyridine nucleotide cytochrome reductase-like, FAD-binding domain
- FAD-binding domain, ferredoxin reductase-type
- Riboflavin synthase-like beta-barrel
- Ferredoxin-NADP reductase (FNR), nucleotide-binding domain
- Oxidoreductase NAD-binding domain
- Oxidoreductase FAD-binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYB5R1 as an antibody target. Whether an autoantibody or antibody against CYB5R1 could matter depends on whether native CYB5R1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYB5R1 is annotated at the cell surface, where native CYB5R1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CYB5R1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...